Glanzmanns thrombasthenia synonyms

Glanzmanns thrombasthenia is most commonly referred to by its eponymous name, though it is also known as Glanzmann thrombasthenia or Glanzmann's disease. In medical literature, it is formally classified as a rare hereditary platelet function disorder, and it is sometimes historically referred to as Glanzmann-Naegeli syndrome or constitutional thrombasthenia.

What are the common names and synonyms for Glanzmanns thrombasthenia?

While Glanzmanns thrombasthenia is the standard term used by clinicians, you may encounter several alternative names in medical records, older textbooks, or international literature. The condition is frequently abbreviated as GT. Because it is a rare bleeding disorder, historical nomenclature often focused on the clinical presentation of the patient rather than the underlying genetic mechanism. Names such as "constitutional thrombasthenia" or "thrombasthenia of Glanzmann and Naegeli" reflect the early 20th-century origins of its discovery. You may also see it referred to as "platelet glycoprotein IIb/IIIa deficiency," which describes the specific protein defect responsible for the disease.

Why does Glanzmanns thrombasthenia have so many different names?

The variety of names for Glanzmanns thrombasthenia stems from the evolution of medical diagnostics. In 1918, Eduard Glanzmann first described the condition, leading to the eponymous naming convention. As our understanding of hematology progressed, the term "thrombasthenia" (meaning weak platelets) was supplemented by more precise biochemical descriptors. The shift toward naming the disease based on the specific molecular defect—such as ITGA2B or ITGB3 gene mutations—has helped standardize international classification, though the original eponymous name remains the most widely recognized term in clinical practice.

How is Glanzmanns thrombasthenia classified in medical databases?

To ensure consistency across global healthcare systems, Glanzmanns thrombasthenia is assigned specific codes in major medical databases. These identifiers are essential for patients and researchers to locate accurate clinical data and insurance coverage information:

• Orphanet: ORPHA833 (recognized as a rare bleeding disorder).


• OMIM (Online Mendelian Inheritance in Man): #273800 (Glanzmann thrombasthenia).


• ICD-10: D69.1 (Qualitative platelet defects).


• NIH GARD: Glanzmann thrombasthenia is indexed under this specific identifier for patient education.

Which name should I use when speaking with my doctor?

When communicating with your hematologist or primary care physician, Glanzmanns thrombasthenia (or simply "Glanzmann's") is the preferred and most universally understood term. Using this name ensures that your medical team immediately recognizes the condition as an inherited platelet function disorder. If you are accessing international records or older clinical reports, keeping the abbreviation "GT" or the term "platelet glycoprotein IIb/IIIa deficiency" in your personal medical file can also be helpful for quick reference. Currently, 59 members of the DiseaseMaps.org community have identified themselves as having this condition, and they consistently use Glanzmanns thrombasthenia to connect with others and share experiences.

Next steps

• Consult a hematologist specializing in rare coagulation or platelet disorders to confirm your specific subtype.


• Request a copy of your genetic test results to confirm the exact mutation, which may be referenced in your records by the gene name rather than the clinical name.


• Join the Glanzmanns thrombasthenia community on DiseaseMaps.org to connect with others who have navigated the complexities of this diagnosis.


• Keep a "medical passport" that lists both the common name (Glanzmanns thrombasthenia) and the specific ICD-10 code (D69.1) to assist emergency responders.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Rare Disease Database (ORPHA833).


• NIH Genetic and Rare Diseases Information Center (GARD).


• OMIM: Online Mendelian Inheritance in Man (Entry #273800).


• DiseaseMaps.org community data and patient resources.